The great wall: why overseas sponsors are yet to fully tap into China’s clinical trial resources
China is an attractive study destination, yet our data-driven analysis shows the country’s clinical trial industry is still insular. Clinical…
By
Outsourced Services
Latest in
Outsourced Services
The E in ESG: how CROs aim to leave a positive ecological mark
Clinical Trials Arena reviews publicly available ESG reports to see how CROs are looking to make improvements to their environmental…
By
CRO M&A deals reach new record, but what does this mean for clinical trial sponsors?
While CRO M&A diversifies a clinical trial service provider’s offering, it could also risk of a changing work culture.
By
DCT Adoption Tracker: Top 3 clinical trial decentralisation trends in Q1 2022
Clinical Trials Arena updates its exclusive taxonomic review of decentralised clinical trials with a spotlight on notable shifts in the…
By
A shallow pool of DCT professionals to meet jobs vacancy boom?
As the clinical trials sector sets records for vacancies for jobs focusing on decentralisation, Clinical Trials Arena investigates professional pathways…
By
Valneva could outsource Covid-19 vaccine manufacturing in response to demand
Valneva maps authorisation and manufacturing plans on the heels of positive Phase III Covid-19 vaccine data.
By
Novavax at risk of losing time advantage once Covid-19 vaccine competitors flex production muscle
Competitor protein subunit Covid-19 vaccine manufacturers are slowly closing in at Novavax’s lead.
By
Globalisation of US cancer trials is reducing enrolment of Black patients, study finds
The increasing globalisation of US-initiated cancer clinical trials is linked to lower enrolment of Black patients, a new study has…
By